Baudax Bio Inc reports results for the quarter ended in June - Earnings Summary

Baudax Bio

06/08/2021 16:42

* Baudax Bio Inc  BXRX.OQ  reported a quarterly adjusted loss
of 23 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 20 cents per share.
* Revenue fell 42.4% to $201.00 thousand from a year ago; 
analysts expected $466.67 thousand. 
* Baudax Bio Inc's reported EPS for the quarter was a loss of 21
cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Baudax Bio Inc shares had fallen by 26.4% this quarter and
lost 44.6% so far this year.
* The company reported a quarterly loss of $15.33 million.
* Wall Street's median 12-month price target for Baudax Bio Inc
is $2.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 6 at 03:42 p.m.  ​All
figures in US dollars unless otherwise stated